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Abstract: An efficient annulation involving pyrone addition to a 
quinone and Dieckmann condensation has been developed for rapid 
assembly of a γ-naphthopyrone monomeric precursor to the bis-
naphthoquinone natural product aurofusarin. Dimerization was 
achieved through Pd(II)-catalyzed dehydrogenative coupling. Further 
studies employing asymmetric nucleophilic epoxidation indicate that 
the atropisomers of aurofusarin and derivatives are not 
configurationally stable at ambient temperature. 
Naphthopyranone natural products[1] are widely found in 
nature and typically possess the 1H-naphtho-[2,3-c]pyran-1-one 
core structure as present in the dimer xanthomegnin (1)[2] (Figure 
1). Aurofusarin (2)[3] and the bis-epoxyquinol diaporine (4),[4] an 
inhibitor of macrophage differentiation which induces conversion 
from the M2 ("repair-type") to the M1 (“kill-type”) phenotype, are 
likely derived from the monomeric naphtho-γ-pyrone rubrofusarin 
(3).[5] Such γ-naphthopyranone scaffolds are difficult to access 
and there are few reported syntheses to date. For example, 
rubrofusarin (3) was previously synthesized in 14 steps in low 
yield[6] and a formal synthesis of 1 was achieved from a 
monomeric precursor (semi-vioxanthin).[2] 
 
Figure 1.  Aurofusarin (2) and related dimeric natural products. 
Herein, we report a concise synthesis of the γ-
naphthopyranone monomeric unit and its Pd-catalyzed 
dehydrogenative dimerization to a biaryl precursor for aurofusarin. 
Based on the work of Thomson and coworkers concerning 
bismurrayaquinone A (5)[7] and seminal work by Shair and 
coworkers on dimeric methoxyquinone-containing natural 
products,[8d] we wondered whether the atropisomers of bis-
naphthoquinones such as (1)[2] and (2) are configurationally 
stable.  Accordingly, we have studied the question of axial chirality 
of 2 as it is crucial for the enantioselective synthesis of the 
congener diaporine (4). 
Retrosynthetically, we envisioned that aurofusarin (2) may 
be accessed through oxidation of biaryl precursor 6 (Scheme 1). 
Construction of biaryl 6 requires highly selective conditions for 
oxidative dimerization, considering possible oxidation of 7 to a 
naphthoquinone. We proposed that monomer 7 may be obtained 
from aryl pyrone 8, a compound derived from tandem Michael 
addition/Dieckmann condensation of methoxy benzoquinone 9[8] 
and dienol ether 10. Compound 10 may be accessed from the 
commercially available dimethyl -pyrone 11.  
Scheme 1.  Retrosynthetic analysis for aurofusarin.   
To prepare substituted pyrone 8, we envisioned that 
treatment of 11 with trimethylsilyl triflate (TMSOTf) should afford 
a siloxypyrylium intermediate[9] which may be deprotonated under 
basic conditions. Accordingly, 11 was consecutively treated with 
TMSOTf and 2,6-lutidine, which was followed by addition of 
quinone 9.[10] Acidic conditions for workup (aq. HCl) were found to 
be crucial for fomation of 8, as a basic workup using tetra-N-
butylammonium fluoride (TBAF) afforded an undesired 
benzofuran product[11] (Scheme 2). To overcome difficulties 
encountered in the monomethylation of 8, -pyrone 12 was 
synthesized via a double-methylation/selective demethylation 
sequence and was further converted to MOM ether 13. We next 
evaluated Dieckmann cyclization of 13. To our delight, use of 
lithium diisopropylamide (LDA) as base produced a 30% yield of 
the desired product 14 which was further improved to 77% using 
degassed solvent. Methylation of 14 with Cs2CO3/dimethyl sulfate 
(Me2SO4) in degassed acetone led to 15 which was treated with 
trifluoroacetic acid (TFA) in CH2Cl2 to afford monomer 16 for 
dimerization studies. 
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Scheme 2.  Synthesis of a 9-hydroxy rubrofusarin derivative. 
Inspired by studies on the biosynthesis of aurofusarin in 
which dimerization was shown to be catalyzed by Gip1, a copper-
containing laccase enzyme,[12] we wished to mimic this process 
using metal-mediated, oxidative conditions. Accordingly, we 
initiated dimerization studies using copper salts with diamine 
ligands[13a] which have been widely used in biaryl couplings. 
However, in general conditions employing single electron 
oxidation metal catalysts such as NH4VO3, FeCl3, SnCl4 and 
AgOTFA only led to the production of a monomeric 
naphthoquinone product.[11,13]   
Table 1.  Dehydrogenative coupling of monomer 16.  
 
entry ligand solvent temp. time yield[a] (conv.[b]) 
1 none DMSO 70 ºC 20 h  23% (30%) 
2 Ac-L-Leu-OH DMSO 70 ºC 4 h 77% (100%) 
3 Ac-L-Leu-OH DCE 70 ºC 24 h 35% (47%) 
4 Ac-L-Leu-OH DMA 70 ºC 4 h decomposition 
5 Boc-L-Pro-OH DMSO 70 ºC 14 h 28% (41%) 
6 Boc-L-Val-OH DMSO 70 ºC 12 h 48% (81%) 





Scheme 3.  Synthesis of aurofusarin from the protected dimer (±)-18. 
We reasoned that the electron-rich substrate 16 may require 
milder oxidative coupling conditions which prompted our 
investigation of palladium-mediated, dehydrogenative 
coupling.[14] After considerable experimentation, we found that 
treatment of 16 with Pd(OAc)2 (10 mol%) in DMSO afforded dimer 
(±)-17 (Table 1, entry 1). However, to achieve full conversion, a 
stoichiometric amount of Pd(OAc)2 was required. Encouraged by 
these results, we evaluated a number of ligands to facilitate 
catalyst turnover. Yu and coworkers[15] have demonstrated that 
monoprotected amino acids can be utilized as chiral ligands in 
asymmetric C−H bond activation. Accordingly, we evaluated use 
of monoprotected amino acids with Pd(OAc)2. Treatment of 16 
with catalytic Pd(OAc)2 and N-acetyl-L-leucine under aerobic 
conditions led to dimer (±)-17 after heating at 70 ºC for 4 h (entry 
2). The structure of (±)-17 was unambiguously confirmed by X-ray 
crystallographic analysis.[16] Evaluation of solvents showed that 
anhydrous DMSO provided optimal results while non-coordinating 
solvents such as DCE (entry 3) led to lower reactivity. Other 
monoprotected amino acid ligands were found to be less effective 
for the transformation (entries 5-6). Among chiral amino acid 
ligands evaluated, we unfortunately did not observe 
atropselectivity for the biaryl product 17.[17] 
Attention was next turned to the synthesis of aurofusarin (2) 
(Scheme 3). Treatment of (±)-17 with ceric ammonium nitrate 
(CAN) led to formation of bis-naphthoquinone 18 (88% yield). 
Synthesis of aurofusarin (2) was achieved on a gram scale in 78% 
yield by selective demethylation of 18 using BBr3. To study the 
atropisomeric stability of the bis-naphthoquinone moiety, a gram-
scale synthesis of (±)-17 (cf. Table 1) was achieved and the 
compound subjected to deracemization using Cu(I)/(+)-
sparteine.[18] Optimal conditions involved in situ generation of a 
stoichiometric copper(II)/sparteine complex which led to 71% 
mass recovery and (–)-17 in 95% ee ([α]d25 = –45°, c = 0.1, 
CH2Cl2) (Scheme 4). Determination of the absolute configuration 
of (–)-17 was attempted using X-ray crystallography, but only a 
chiral, racemic crystal of (±)-17 was obtained. Presumably, 
photoracemization of (–)-17 (max = 405 nm) may occur during 
crystallization via excited state intramolecular proton transfer.[11,19] 
 
 
Scheme 4.  Deracemization of biaryl 17. 
To determine whether the atropisomers of bis-
naphthoquinone 18 are configurationally stable, (–)-17 was 
oxidized with CAN (Scheme 5a). Analytical chiral HPLC analysis 
of the resulting bis-quinone 18 did not reveal enantiomer 
separation, and, additionally, no optical rotation was observed.[11] 
Accordingly, further derivatization of 18 to epoxide 19 was 
performed. Epoxidation by NaOCl afforded bis-epoxide 19 as a 
single diastereomer. However, from chiral HPLC analysis, 
compound 19 derived from (–)-17 was racemic which further 
supports that the atropisomers of 18 are likely rapidly 
interconverting. The relative stereochemistry of bis-epoxide 19 
was further studied by the model reaction shown in Scheme 5b. 
Model bis-quinone 20[20] was treated with NaOCl in CH3CN to 
afford epoxide 22 as a single diastereomer in 78% yield and the 
relative stereochemistry of 22 was determined by X-ray 
crystallographic analysis.[16] From this model reaction, it appears 
that the cis-relationship of the epoxides in 22 is derived from 





epoxidations anti to the methoxy groups in the bisected bis-
quinone conformer 21.  
 
 
Scheme 5.  Synthesis of bis-epoxide 22 and a model study for epoxidation. 
Based on the reactivity observed, we envisioned that 
asymmetric epoxidation of 18 derived from (±)-17 could be utilized 
to further validate our hypothesis for atropisomeric instability of 
18.[20] Asymmetric nucleophilic epoxidations of enones have been 
extensively studied,[21] but are generally conducted on simple 
monomeric quinones.[22] Accordingly, a series of phase transfer 
catalysts (PTC’s) were examined which showed that cinchonine-
derived catalysts 23 and the corresponding dimeric cinchonine 
catalyst 24 provided up to 75% ee. We ultimately identified the 
Maruoka phase transfer catalyst 25[23] (Scheme 7) as a suitable 
catalyst for asymmetric epoxidation which afforded bis-epoxide 
()-19 in 62% yield and 97% ee as a single diastereomer. The 
absolute configuration of ()-19 was determined by comparison of 
the experimental electronic circular dichroism (ECD) spectrum 
with calculated spectra.[11] In this reaction, four stereocenters are 
formed in high selectivity.  
 
 
Scheme 6. Dynamic kinetic resolution in asymmetric nucleophilic epoxidation.  
A number of factors have been cited to contribute to 
atropisomeric stability of bis-quinones, including carbonyl bond 
lengths[7] and out-of-plane-distortions.[7] Shair and coworkers 
have provided a rationale for the pH-dependent atropisomerism 
of the methoxyquinone-containing natural product hibarimicinone 
which involves cross-conjugated resonance structures.[8d] While 
related contributing zwitterionic structures and deviation of the 
quinone carbonyl group from planarity may be relevant for 
xanthomegnin 1 and aurofusarin 2,[11] a comparison of the X-ray 
structures of 1 and 5 along with a DFT model of 2 (Figure 2) also 
shows shortening of the C-OCH3 bond of 1 and 2 (1.342 Å and 
1.337 Å) in comparison to the C-CH3 bond length of 5 (1.479 Å). 
This bond shortening appears to be a factor in lowering the barrier 
for atropisomerization of 2. The calculated barrier for 18 (24.6 
kcal/mol, B3LYP/6-31G(d))[11, 24] is also similar to the energy 
barrier for interconversion of atropisomers (22.2 kcal/mol) 
suggested by Ōki.[25] 
Figure 2. Bond length analysis of the X-ray structures of 1 and 5 along with a 
DFT model of 2.  
 
In summary, we have developed an efficient annulation 
involving pyrone addition to a quinone for rapid assembly of a γ-
naphthopyrone monomer enroute to the natural product 
aurofusarin. Dimerization of the γ-naphthopyrone was achieved 
through Pd(II)-mediated dehydrogenative coupling wherein a 
simple mono-protected amino acid was found to be a suitable 
ligand for a catalytic process. In addition asymmetric nucleophilic 
epoxidation of aurofusarin derivative 18 supports the hypothesis 
that the atropisomers of bis-methoxy naphthoquinones such as 
aurofusarin are not configurationally stable. Extension of the 
methodology to access an enantioenriched bis-epoxide 
intermediate for the synthesis of diaporine is currently in progress 
and will be reported in due course. 
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A rapid synthesis of a γ-naphthopyrone precursor to the natural product aurofusarin 
has been achieved using a Michael addition/Dieckmann sequence. Pd(II)-catalyzed 
dehydrogenative coupling followed by selective demethylation afforded the bis-
naphthoquinone aurofusarin. Further studies showed that the atropisomers of bis-
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